Vaccine Toes Are the New COVID Toes

Area of Science:

• Dermatology
• Vaccinology
• Immunology

Background:

• Pernio-like lesions were identified as a dermatologic manifestation of COVID-19 in May 2020.
• Following the introduction of mRNA COVID-19 vaccines in December 2020, nine reports of vaccine-associated pernio-like lesions have been documented.

Observation:

• A male patient in his 60s presented with pernio-like lesions on his toes.
• These lesions appeared approximately one week after his second dose of the Pfizer-BioNTech mRNA COVID-19 vaccine.
• The patient's symptoms resolved within six weeks.

Findings:

• The increasing reports of pernio-like lesions post-vaccination highlight the link between a patient's pathophysiological state and dermatological reactions.
• These lesions are hypothesized to indicate a robust host immune response, possibly involving interferon-1 production, similar to responses seen in primary COVID-19 infection.
• The occurrence of these lesions after vaccination supports the theory of a heightened immune response.

Implications:

• Media reporting on vaccine-associated pernio-like lesions can inadvertently foster vaccine hesitancy.
• Clinicians can leverage the discussion of "COVID toes" as an opportunity to educate patients about vaccine responses and build trust in evidence-based medicine.
• Understanding these dermatological manifestations is crucial for accurate patient counseling and addressing public concerns regarding COVID-19 vaccines.